The Efficacy of topical Capsaicin in the management of painful diabetic peripheral neuropathy: A unicenter double-blind, randomized clinical trial
- Conditions
- Nutritional, Metabolic, Endocrine
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 22
All were patients with type 2 diabetes who had daily pain or painful paresthesias in a neuropathic or radiculopathic distribution, intensity between 4 and 7 on a visual analogic scale, interfering with daily activities, work or sleep for at least 3 months duration.
•History of allergies to any capsaicin product
•Diabetic patients with other diagnosed etiology responsible for peripheral neuropathy such as hepatitis, AIDS, Nutritional deficiencies (folate, vitamin B12)
•Presence of open skin lesions at the site of application of the study medication
•Signs of infection on limbs or amputations
•Pregnant or lactating females
•Subjects with other topical medication at site of application of study cream.
•All eligible patients who did not give their signed informed consent to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
